Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations
- 23 June 2016
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 78 (2) , 377-382
Abstract
The relationship between plasma concentration and antitumor activity of gefitinib was assessed in patients with advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations.Keywords
This publication has 10 references indexed in Scilit:
- Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokineticsCancer Chemotherapy and Pharmacology, 2013
- Molecular pharmacokinetic determinants of anticancer kinase inhibitors in humansOncology Reviews, 2011
- Clinical Pharmacokinetics of Tyrosine Kinase InhibitorsClinical Pharmacokinetics, 2011
- Pharmacokinetics of Gefitinib Predicts Antitumor Activity for Advanced Non-small Cell Lung CancerJournal of Thoracic Oncology, 2010
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFRNew England Journal of Medicine, 2010
- The relationship between drug exposure and clinical outcomes of non-small cell lung cancer patients treated with gefitinibMedical Oncology, 2010
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trialThe Lancet Oncology, 2010
- Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancerLung Cancer, 2008
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Ion-pair reversed-phase high-performance liquid chromatography of adenine nucleotides and nucleoside using triethylamine as a counterionJournal of Chromatography B: Biomedical Sciences and Applications, 1997